About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,968 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,968 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3581-3600 of 18,968 trials

Active not recruitingPre- and Post- Descriptive Data of Language Outcomes in Deaf ChildrenDeaf children between ages of 4-10 will provide pre and post data by responding to three prompts in sign language and written language at the beginning and end of a year.NCT06724523·Knoxville, Tennessee CompletedThrombin Regulated Platelet ActivationThrombin is the most potent activator of platelets, and platelet activation is a hallmark of thrombosis.NCT00855296·Nashville, Tennessee

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedTirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00020696·Birmingham, Alabama and 53 others

Active not recruitingA Study Evaluating BFB759 in Moderate to Severe Atopic DermatitisThis is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks.NCT07105488·Phoenix, Arizona and 87 others

RecruitingAlleviant ALLAY-HF StudyProspective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt…NCT05685303·Phoenix, Arizona and 92 others

CompletedVELOCITY: An Anthrax Vaccine Clinical StudyThis study is designed to evaluate the lot consistency (using three consecutively manufactured lots), safety, and ability of the AV7909 anthrax vaccine to generate an immune…NCT03877926·Birmingham, Alabama and 34 others

CompletedAdjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and NeckRATIONALE: Monoclonal antibodies such as cetuximab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00084318·Birmingham, Alabama and 159 others

CompletedA Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and CapecitabineThe purpose of this study is to evaluate the efficacy and safety of E7389 in Patients with locally advanced or metastatic breast cancer, previously treated with anthracycline…NCT00246090·Birmingham, Alabama and 64 others

UnknownThe Management of Diabetes in Everyday Life ProgramThe overall goal of this study is to compare how well motivational messages (text messages from the doctor's office), diabetes health coaches, and enhanced usual care with…NCT02957513·Holly Springs, Mississippi and 18 others

TerminatedLuveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLThis trial will evaluate whether luveltamab tazevibulin is well tolerated and active against a rare form of AML carrying a particular genetic abnormality called CBFA2T3::GLIS2…NCT06679582·Birmingham, Alabama and 35 others

CompletedIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaRATIONALE: Intravenous VEGF Trap may stop the growth of solid tumors or non-Hodgkin's lymphoma by stopping blood flow to the cancer.NCT00082823·New York, New York and 1 other

CompletedA Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderThe primary objective is to evaluate the efficacy of monthly 225 mg sc fremanezumab in adult participants with migraine and major depressive disorder (MDD) The secondary…NCT04041284·Little Rock, Arkansas and 63 others

TerminatedPolyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00054184·Hoover, Alabama and 34 others

CompletedMacular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy TrialThe Macular Edema Ranibizumab v.NCT02623426·Los Angeles, California and 32 others

CompletedImproving Outcomes in Neonatal Abstinence Syndrome1: SPECIFIC Aim I: To compare treatment options for neonatal abstinence syndrome (NAS) due to in-utero narcotic exposure.NCT01958476·Jacksonville, Florida and 7 others

CompletedEvaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected AdultsThis study will evaluate the safety, tolerability, and immune response to different combinations of two experimental HIV vaccines-the DNA-HIV-PT123 vaccine and the AIDSVAX® B/E…NCT02207920·San Francisco, California and 6 others

Active not recruitingA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of…NCT05552976·Mobile, Alabama and 203 others

CompletedEfficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to severely active CD who…NCT02611817·Phoenix, Arizona and 193 others

Not yet recruitingA Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)This study is open to adults with extensive-stage small cell lung cancer.NCT07843940·Miami, Florida and 26 others

CompletedSingle Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in ChildrenThis is a multicenter trial to evaluate the single-dose safety, tolerability and pharmacokinetics-pharmacodynamics of Zolpidem in a group of children with sleep disturbances…NCT00494468·Little Rock, Arkansas and 10 others

PreviousPage 180 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee